Business Press Release Tech Inaugural Asia FII PRIORITY Summit Powered By FII Institute To Take Place In Hong Kong On 7 & 8 December FII PRIORITY Hong Kong Summit, held in partnership with the Government of… CISION PRNewswireDecember 6, 2023
Press Release Feel the charm of exquisite city, promote economic and trade cooperation with Nicaragua between enterprises WEIHAI, China, Dec. 6, 2023 /PRNewswire/ — A report from dzwww.com: jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=” … CISION PRNewswireDecember 6, 2023
Press Release Tech TV360 Acquires Exclusive Broadcasting Rights For Euro 2024 HANOI, Vietnam, Dec. 6, 2023 /PRNewswire/ — Viettel Telecom, the leading telecommunications… CISION PRNewswireDecember 6, 2023
Business Press Release WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader SUZHOU, China, Dec. 6, 2023 /PRNewswire/ — WuXi Vaccines, a leading global… CISION PRNewswireDecember 6, 2023
Business Press Release Tech VERTICAL INSTITUTE REVOLUTIONISES CAREER DEVELOPMENT WITH CUTTING-EDGE COURSES AND EXPERT-LED INSTRUCTION Vertical Institute (VI) is a leading provider of cutting-edge courses, addressing the… CISION PRNewswireDecember 6, 2023
Press Release Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma XPOVIO® (selinexor) is the first and only exportin 1 (XPO1) inhibitor approved… CISION PRNewswireDecember 6, 2023
Press Release Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8% JINAN, China, Dec. 6, 2023 /PRNewswire/ — Qilu Pharmaceutical presented the latest… CISION PRNewswireDecember 6, 2023
Press Release Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas KUALA LUMPUR, Malaysia, Dec. 6, 2023 /PRNewswire/ — AstraZeneca’s Koselugo (selumetinib) is… CISION PRNewswireDecember 6, 2023
